Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study)

Which dyskinesia scale best detects treatment response?

(2013) Christopher G. Goetz et al.   MOVEMENT DISORDERS

Treatment patterns and associated costs with Parkinson's disease levodopa induced dyskinesia

(2012) Dong-Churl Suh et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Psychosis in Parkinson's disease without dementia: Common and comorbid with other non-motor symptoms

(2012) Angela H. Lee et al.   MOVEMENT DISORDERS

Calibration of unified Parkinson's disease rating scale scores toMovementDisorder Society-unified Parkinson's disease rating scale scores

(2012) Christopher G. Goetz et al.   MOVEMENT DISORDERS

A 12-Year Population-Based Study of Psychosis in Parkinson Disease

(2010) Elin B. Forsaa et al.   ARCHIVES OF NEUROLOGY

Long-term antidyskinetic efficacy of amantadine in Parkinson's disease

(2010) Elisabeth Wolf et al.   MOVEMENT DISORDERS

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS